4//SEC Filing
Backstrom Jay T. 4
Accession 0001439222-25-000080
CIK 0001439222other
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 4:14 PM ET
Size
7.8 KB
Accession
0001439222-25-000080
Insider Transaction Report
Form 4
Backstrom Jay T.
Director
Transactions
- Award
Restricted stock units
2025-07-08+4,341→ 4,341 total→ Common stock (4,341 underlying) - Award
Stock options (right to buy)
2025-07-08+23,393→ 23,393 totalExercise: $36.28Exp: 2035-07-08→ Common stock (23,393 underlying)
Footnotes (3)
- [F1]This option was granted on July 8, 2025. The shares underlying this option vest as to 25% of the underlying shares on July 8, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F3]The restricted stock units were granted on July 8, 2025. Beginning on July 8, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001796398
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 4:14 PM ET
- Size
- 7.8 KB